BIR Theranostics update 2021

21st January 2021 13:00 - 16:00 (GMT+00:00) GMT

Virtual event – Thursday 21 January 13:00-16:00 GMT
CPD: 3 points

This half-day virtual event will cover the exciting concept of theranostics. This session will discuss the use of theranostics in the imaging and therapy of primarily oncological conditions. Our renowned international multidisciplinary faculty of expert oncologists, radiopharmacists, radiologists, physicists and nuclear medicine physicians will provide a comprehensive overview of imaging technology and therapies. Attendees will develop their skills in theranostics with talks covering radiological imaging, PET/CT, radionuclide therapy, regulatory requirements and new theranostic tracers.

This virtual event will be of interest to all nuclear medicine physicians, radiologists, oncologists, onco-surgeons, trainees, clinical physicists, technologists and healthcare managers.

View the virtual event programme here

The session will be recorded if you are unable to attend on the day and will be available on-demand to those who have registered.

Further updates
Follow us on Twitter @BIR_News or sign up for our email alerts here to get further updates on our educational programmes
Become a member of the BIR to gain access to hundreds of other webinars and online learning tools for free today!

EARLY BIRD Registration fees:
Non members £65
Plan 1 members £45
Plan 2/Trainee members £35
Retired/student member £30
*EARLY BIRD rates expire on Monday 21 December 2020

Registration fees:
Non members £80
Plan 1 members £55
Plan 2 members £45
Trainee members £45
Retired/student member £35

*VAT will be added at checkout, where applicable

Payment for all events must be made via a debit or credit card. Invoices and PO numbers cannot be used for registration payment. If you need your hospital, Trust, or organisation to pay for registration fees please have them contact our events team at conference@bir.org.uk. Please note VAT will be added for all virtual events to the registration fees listed. For any further inquiries please contact conference@bir.org.uk

If you are having issues registering for the event please create or login to your MyBIR account via this link and then register for the event after you have logged in. If you are still experiencing any issues please email conference@bir.org.uk

Venue

Speakers

Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.

Bayer Healthcare

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk

Blue Earth Diagnostics

Blue Earth Diagnostics is a leading molecular imaging diagnostics company focused on the development and commercialization of novel PET imaging agents to inform clinical management and guide care for cancer patients in areas of unmet medical need. The company’s first approved and commercially available product is Axumin® (fluciclovine F 18). Blue Earth Diagnostics is a subsidiary of Bracco Imaging S.p.A..

Curium Pharma UK Ltd

Curium is a world-class nuclear medicine solutions provider with more than a century of industry experience. With manufacturing facilities across Europe and the United States, Curium supports over 14 million patients around the word with SPECT, PET and therapeutic radiopharmaceuticals to provide potentially life-saving diagnostic solutions and therapy.

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

MIM Software Inc

MIM Software provides solutions in Radiology, Nuclear Medicine, and Radiation Oncology. MIM’s products emphasize the importance of quantitation, collaboration, and data management to provide physicians with the necessary information needed to generate confident clinical guidance and to inform effective treatments. MIM SurePlan™ products provide timesaving tools for organ and tumor segmentation, deformable registration, and voxel-based dosimetry. SurePlan offers reporting solutions that provide more information about the treatment course. https://go.mimsoftware.com/eu/personalized-dosimetry

OncoBeta

OncoBeta® GmbH with its headquarters located at the Garching Technology and Founders Center GATE near Munich, is a privately held medical device and radiochemical company specialized in the development and commercialization of state-of-the-art, innovative therapies utilizing epidermal radioisotope applications. Since its foundation, OncoBeta® GmbH has concentrated its efforts on the development, regulatory approval(s) and commercialization of the epidermal radioisotope therapy Rhenium-SCT® (Skin Cancer Therapy), targeting non-melanoma skin cancers. Since then, OncoBeta® GmbH has successfully perfected the customized application and device management system in conformity with all health, safety, and environmental protection regulatory standards. Since 2019 OncoBeta® GmbH produces tungsten (wolfram)-188/rhenium-188 (188W/188Re) Generators for commercial use. Find out more about the Rhenium-SCT® at www.oncobeta.com Follow us on social media: LinkedIn: https://www.linkedin.com/company/oncobeta-gmbh/ Facebook: https://www.facebook.com/OncoBeta/

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare

Siemens Healthineers

At Siemens Healthineers, our mission is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated five million patients worldwide everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine as well as digital health and enterprise services. We're a leading medical technology company with over 120 years of experience and 18,500 patents globally. With over 50,000 employees in more than 70 countries, we'll continue to innovate and shape the future of healthcare. For more information and latest product line, please visit www.siemens-healthineers.co.uk